冠心病抗炎治疗的临床研究进展
Clinical Research Progress in Anti-Inflammatory Therapy of Coronary Heart Disease
庄文文 1杜明亮 1惠慧 1郑晓群1
作者信息
- 1. 大连市中心医院冠心病科,辽宁大连 116032
- 折叠
摘要
炎症是导致冠心病发生和发展的重要因素,抗炎治疗成为进一步降低冠心病残余风险的希望,然而目前临床上并无规范的抗炎治疗策略.近年来多项大规模的随机、双盲对照试验为寻找冠心病的抗炎治疗策略指引了方向.现结合近年来循证证据就冠心病抗炎治疗的进展做一综述.
Abstract
Inflammation can lead to the development of coronary heart disease(CHD),and anti-inflammatory therapy has become the hope to further reduce the residual risk of CHD.However,there is no standard anti-inflammatory therapy strategy in clinical practice.In recent years,a number of large-scale randomized,double-blind,placebo-controlled clinical studies have guided the search for anti-inflammatory therapy for CHD.This article reviews the progress of anti-inflammatory therapy for CHD based on evidence-based research in recent years.
关键词
冠心病/抗炎治疗/残余炎症风险Key words
Coronary heart disease/Anti-inflammatory treatment/Residual inflammation risk引用本文复制引用
出版年
2024
NETL
NSTL
万方数据